深圳市医药行业协会（Shenzhen Medicine Profession Association ，简称SMPA），是1988年经市民政局批准成立的全市性社会团体法人组织。深圳市医药行业协会是政府医药主管部门的助手和参谋，接受市卫计委、市食药监局的业务指导，在政府和企业之间积极发挥桥梁和纽带作用。其宗旨是为医药（包括医疗器械、药品、生物制品、卫生材料、化学试剂、玻璃仪器、药用包装材料）生产、经营企业、科研机构服务，维护会员单位的合法权益，促进医药行业的健康发展。  

  Shenzhen Medicine Profession Association (SMPA for short) was established in 1988 as a legal NGO  approved by Shenzhen Municipal Civil Affairs bureau. Shenzhen Medicine profession Association is one of assistants of Shenzhen Government department of Health, following the guidance of Shenzhen Health & Family Planning Commission, Shenzhen Food & Drug Administration, acting as a bridge between government and enterprises. The aim of our association is to provide professional services for medical enterprises (including medical equipment, pharmacy, biological products, sanitary materials, chemical reagents, glass equipment, pharmaceutical packaging materials) and scientific research institutions , protecting the legal rights and interests of our members, promoting the healthy development of the medical industry.

  历任会长有：深圳三九集团有限公司前董事长赵新先，深圳市药监局前副局长修成娟，现任会长深圳市赛百诺基因技术有限公司徐卫总裁。现有会员企业200余家，基本上涵盖了深圳知名医药及国际顶尖创新生物企业；和牛津、剑桥、哈佛、以色列理工大学等国际知名高校科技部门建立了良好的研发、培训、互访机制，并建立了共同推进项目的研究院；拥有国家知名院士、科学家组成的委员会，在新药研发、国内外新药注册及专利转化方面切实帮助会员企业；同时，在国家、省、市食药局、发改委、科创委等政府职能部门的支持下，对药事新政解读、互联网＋时代下的医药行业发展解决方案等方面已经形成了权威成熟的系列培训，同时，协会组织了大量的国际交流活动和高端医药论坛。协会致力于“打造医药行业服务平台，引领医药产业发展未来”，在政府和企业的支持下，共同开拓医药产业广阔的空间。 

  Now we have more than 200 member enterprises, basically covering most of Shenzhen  well-known pharmaceutical and international top biological innovation enterprises, corporating with science and technology department of international famous university such as Oxford, Cambridge, Harvard, Israel's university of science and technology and other international well-known colleges and universities. We has set a good routine of research and development, training, exchange of visits, and built up some institutions for some  projects. Our specialist commission has recruited international well-known academicians, scientists, to help our members in new drug research and development, domestic and international new drug registration and transformation of drug patents. At the same time, under the support of government, our commission provides a series of training with authoritative and mature resources. Moreover, we organized a large number of international exchange activities, and highly appreciated medical forums. We devoted to "Create the pharmaceutical industry service platform, Lead the future of medical industry development”, with the support of government and enterprises, exploiting potential of medicine industry market together.